Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Population Screening Market In The Coming Years?
In recent times, there has been a significant expansion in the size of the population screening market. It is projected to expand from $29.31 billion in 2024 to $31.39 billion by 2025, following a compound annual growth rate (CAGR) of 7.1%. The upsurge in historical period growth is mainly due to initiatives aimed at preventing disease, government health regulations, the escalation in healthcare expenses, and heightened awareness of disease.
The market scale of population screening is anticipated to witness substantial expansion in the future. With a compound annual growth rate (CAGR) of 7.2%, it is projected to reach $41.4 billion by 2029. Factors contributing to this growth for the projected period are the move towards bespoke medicine, an upward aging trend and the prevalence of chronic conditions, integration of artificial intelligence and data analytics, as well as widening access to screening. Key market trends during this period are projected to be medical technology advancements, genetic studies and precision screening, telehealth and remote screening services, screening panels for multiple diseases, along with health equality and accessibility.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Population Screening Market?
The increase in cancer incidences is anticipated to fuel the expansion of the population screening market. Cancer happens when certain cells in a person’s body grow abnormally and invade other bodily parts. Early detection of cancer through population screening can lead to more effective treatment and improved prognosis. As an example, the American Cancer Society Inc., a US-based non profit health group, released reports in January 2023 stating that the cancer-related deaths in 2022 were 608,570, with an estimated 1.9 million fresh cancer cases, an increase from 606,520 cancer deaths in the previous year, 2021. As a result, the heightened occurrence of cancer is contributing to the growth of the population screening market.
Which Sub-Segments Are Driving Growth Within The Population Screening Market?
The population screeningmarket covered in this report is segmented –
1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation
2) By Gender: Male; Female
3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above
4) By Business: Hospitals; Research Institutes; Diagnostic Labs
Subsegments:
1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools
What Future-Focused Trends Are Anticipated In The Population Screening Market?
Leading firms in the population screening market are developing progressive services such as newborn mass screening. The goal is to boost early discovery and boost the health outcomes of infants. Newborn mass screening is a public health program that tests newborns for various hidden genetic, metabolic, hormonal, and functional disorders shortly after birth. These conditions might not be immediately obvious, but they can lead to serious health complications if they are not treated quickly. For example, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and subsidiary of Shimadzu Corporation, a Japanese precision instrument manufacturer, rolled out a new contracted service for polymerase chain reaction (PCR) testing for broadened newborn mass screening. This service will test for serious conditions like severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA) which affect a small population of newborns but need urgent attention after identification.
Which Players Are Shaping The Competitive Landscape Of The Population Screening Market?
Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
How Do Regional Dynamics Influence The Population Screening Market Performance?
North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp
Browse Through More Reports Similar to the Global Population Screening Market 2025, By The Business Research Company
Population Health Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/population-health-management-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Cellular Health Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model